Hospitals increasingly give powerful clot-buster for stroke

The use of a potentially lifesaving, clot-busting drug -- called tissue plasminogen activator (tPA) -- to treat patients with ischemic stroke nearly doubled between 2003 and 2011, according to a large new study. Lee Schwamm, HMS professor of neurology at Massachusetts General Hospital, is the leader of the study.

Read full article